Trials / Withdrawn
WithdrawnNCT03968484
Platelet Transfusion in Sepsis Trial
Platelet Transfusion in Sepsis Trial (PlaTiSep)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Platelets are important mediators of an inflammatory response and a key component of the innate immune system to defend the human body against invading pathogens. However, little evidence exists regarding the number of platelets that should be used als transfusion threshold in septic patients. In this trial platelet transfusion will be performed with either \<50000/µl or \<20000/µl as a trigger.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | platelet transfusion | Transfusion of platelets |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2022-08-01
- Completion
- 2023-02-01
- First posted
- 2019-05-30
- Last updated
- 2020-04-10
Source: ClinicalTrials.gov record NCT03968484. Inclusion in this directory is not an endorsement.